The Influence of Finasteride on the Development of Prostate Cancer

Ian M. Thompson, Phyllis J. Goodman, Catherine M. Tangen, +7

New England Journal of Medicine

Phase III study of gemcitabine [G] plus cetuximab [C] versus gemcitabine in patients [pts] with locally advanced or metastatic pancreatic adenocarcinoma [PC]: SWOG S0205 study

P. A. Philip, Jacqueline Benedetti, Cecilia M. Fenoglio‐Preiser, +7

Journal of Clinical Oncology

Surgical OncologyCancer ManagementAdjuvant ChemotherapyPathologyPancreatic Cancer +14

Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer

Silvia Novello, Giorgio V. Scagliotti, Rafael Rosell, +10

British Journal of Cancer

Calgb/Swog 80405: Phase III Trial of Irinotecan/5-Fu/Leucovorin (Folfiri) or Oxaliplatin/5-Fu/Leucovorin (Mfolfox6) with Bevacizumab (Bv) or Cetuximab (Cet) for Patients (Pts) with Expanded Ras Analyses Untreated Metastatic Adenocarcinoma of the Colon Or Rectum (Mcrc)

Heinz‐Josef Lenz, Donna Niedzwiecki, Federico Innocenti, +12

Annals of Oncology

Calgb/swog 80405Colon Or RectumGastrointestinal OncologyMedicinePhase Iii Trial +6

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer

G. Deplanque, Martin Demarchi, Mohamed Hebbar, +13

Annals of Oncology

The impact of sharing results of a randomized breast cancer clinical trial with study participants

Ann H. Partridge, Antonio C. Wolff, P. Kelly Marcom, +11

Breast Cancer Research and Treatment

Study ParticipantsHealth PolicyCancer ScreeningClinical TrialsEducation +8

Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy

Razelle Kurzrock, J. Atkins, Jennifer J. Wheler, +5

Annals of Oncology

Measurement FluctuationsMedicineThyroid DiseaseCancer TreatmentTumor Marker +7

CALGB/SWOG 80405: Phase III Trial of Irinotecan/5-FU/Leucovorin (FOLFIRI) or Oxaliplatin/5-FU/Leucovorin (MFOLFOX6) with Bevacizumab (BV) or Cetuximab (CET) for Patients (PTS) with KRAS Wild-Type (WT) Untreated Metastatic Adenocarcinoma of the Colon

Alan P. Venook, Donna Niedzwiecki, Heinz‐Josef Lenz, +12

Annals of Oncology

Calgb/swog 80405Kras Wild-typeGastrointestinal OncologyMedicinePhase Iii Trial +6

Phase I study pilot arms of radiotherapy and carmustine with temozolomide for anaplastic astrocytoma (Radiation Therapy Oncology Group 9813): implications for studies testing initial treatment of brain tumors

Susan M. Chang, Wendy Seiferheld, Walter J. Curran, +14

International Journal of Radiation Oncology*Biology*Physics

Neuro-oncologyRadiation MedicineGliomaRadiation TherapyMedicine +8

The study of tamoxifen and raloxifene (STAR): Initial findings from the NSABP P-2 breast cancer prevention study

D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel, +7

Journal of Clinical Oncology

Surgical OncologyBreast OncologyCancer ManagementGynecologyPharmacotherapy +19